Correlation Between Pfizer and Freedom 100

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Freedom 100 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Freedom 100 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Freedom 100 Emerging, you can compare the effects of market volatilities on Pfizer and Freedom 100 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Freedom 100. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Freedom 100.

Diversification Opportunities for Pfizer and Freedom 100

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pfizer and Freedom is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Freedom 100 Emerging in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Freedom 100 Emerging and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Freedom 100. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Freedom 100 Emerging has no effect on the direction of Pfizer i.e., Pfizer and Freedom 100 go up and down completely randomly.

Pair Corralation between Pfizer and Freedom 100

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Freedom 100. In addition to that, Pfizer is 1.11 times more volatile than Freedom 100 Emerging. It trades about -0.01 of its total potential returns per unit of risk. Freedom 100 Emerging is currently generating about 0.0 per unit of volatility. If you would invest  3,483  in Freedom 100 Emerging on September 15, 2024 and sell it today you would lose (42.00) from holding Freedom 100 Emerging or give up 1.21% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Freedom 100 Emerging

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Freedom 100 Emerging 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Freedom 100 Emerging has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Freedom 100 is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pfizer and Freedom 100 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Freedom 100

The main advantage of trading using opposite Pfizer and Freedom 100 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Freedom 100 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Freedom 100 will offset losses from the drop in Freedom 100's long position.
The idea behind Pfizer Inc and Freedom 100 Emerging pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stocks Directory
Find actively traded stocks across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume